SLC35D1

Across TCGA pan-cancer cohorts, SLC35D1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC35D1 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher SLC35D1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated SLC35D1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

GBM and HNSC are the cancer types where SLC35D1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Quartile	All	0.200	0.977	.038	6	view →
HNSC	DFS	Quartile	All	1.000	0.789	.027	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SLC35D1–GBM (OS)

Open the GBM breakdown →